药捷安康-B(02617)在2026年AACR展示谱系重塑作为HR+乳腺癌内分泌治疗的耐药机制以及替恩戈替尼的临床前数据
Last Update:
21 4 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.